Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial Academic Article uri icon


  • Van Cutsem, E
  • De Haas, S
  • Kang, YK
  • Ohtsu, A
  • Tebbutt, NC
  • Xu, JM
  • Yong, WP
  • Langer, B
  • Delmar, P
  • Scherer, SJ
  • Shah, MA

publication date

  • 2012